PD Dr. Benjamin Frey

Medizinische Fakultät Department of Radiation Oncology

Longitudinal Spread Analysis of Patients with Glioblastoma: high Prevalence of discontinuous Tumor Foci with no strong Relation to the Fibrous Tract System (2021) Schmitter C, Weissmann T, Mansoorian S, Lettmaier S, Semrau S, Schmidt M, Heiß R, et al. Conference contribution 3D convolutional neural network-based autosegmentation improves brain metastases detection and quantification for brain stereotactic radiotherapy treatment planning (2021) Putz F, Weissmann T, Mansoorian S, Schmidt M, Heiß R, Semrau S, Frey B, et al. Conference contribution The OAR Turing-Test Study: A blinded Comparison of expert-Based Organ at Risk Creation and three commercial Auto-Segmentation Solutions (2021) Putz F, Lamrani A, Weissmann T, Mansoorian S, Frey B, Bert C, Fietkau R Conference contribution Detection of Human Cytomegalovirus (HCMV) in monocytic Cells of the peripheral Blood in Glioma Patients during Radio (chemo) Therapy (2021) Bäumler M, Becker I, Frey B, Pohn A, Winkler T, Fietkau R, Gaipl U Conference contribution Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution The Growth of primary and abscopal Tumors as well as their immunological Microenvironment are differently influenced by different Combinations of Radiation and Immunotherapies (2021) Rückert M, Deloch L, Frey B, Fietkau R, Gaipl U Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy (2021) Hader M, Streit S, Rosin A, Gerdes T, Wadepohl M, Bekeschus S, Fietkau R, et al. Journal article Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy (2021) Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, Gu N, et al. Journal article